Blog
RSS FeedPosted by Michael Wonder on 04 May 2023
Sanders and Klobuchar reintroduce legislation to cut drug prices in half
4 May 2023 - Bill Would Allow Medicare to Pay Same Prices as Veterans Affairs. ...
Posted by Michael Wonder on 01 May 2023
Canada’s health minister denies interfering in agency’s efforts to lower drug costs
27 April 2023 - Health Minister Jean-Yves Duclos says he has not exercised any undue political pressure on the independent ...
Posted by Michael Wonder on 23 Apr 2023
EMA addresses considerations for single-arm trials
21 April 2023 - A new reflection paper from the EMA offers some suggestions to sponsors on how to design ...
Posted by Michael Wonder on 22 Apr 2023
Mifepristone: US Supreme Court preserves abortion drug access
22 April 2023 - The US Supreme Court has preserved access to a commonly used abortion pill, ruling the drug ...
Posted by Michael Wonder on 20 Apr 2023
FDA approval processes for therapeutic drugs must be improved
18 April 2023 - The FDA’s glacial pace at reviewing and approving new drugs has an enormous opportunity cost for ...
Posted by Michael Wonder on 14 Apr 2023
Throwing the baby out with the bath water: Congress considers banning the QALY
3 April 2023 - In late March, the House Committee on Energy and Commerce advanced H.R. 485 - Protecting Health ...
Posted by Michael Wonder on 13 Apr 2023
Regulatory, health technology assessment and company interactions: the current landscape and future ecosystem for drug development, review and reimbursement
11 April 2023 - The aims of this study were to review the current interactions within and across regulatory and HTA ...
Posted by Michael Wonder on 13 Apr 2023
Blocking FDA approval of abortion pill could stifle innovation in the biopharma industry, experts say
13 April 2023 - If courts affirm US District Judge Matthew Kacsmaryk’s decision to suspend the FDA’s approval, it could make ...
Posted by Michael Wonder on 11 Apr 2023
Abortion ruling could undermine the FDA’s drug approval authority
10 April 2023 - Legal scholars say the ruling by a Texas judge, if upheld, could spur disputes over many medications ...
Posted by Michael Wonder on 10 Apr 2023
Health care regulators’ outdated thinking will cost American ives
10 April 2023 - In a matter of months, ChatGPT has radically altered our nation’s views on artificial intelligence—uprooting old ...
Posted by Michael Wonder on 08 Apr 2023
Federal judge stays FDA abortion pill approval, gives Biden administration time to appeal
7 April 2023 - A federal judge in Texas on Friday stayed the FDA’s approval of the abortion pill mifepristone, ...
Posted by Michael Wonder on 07 Apr 2023
FDA Commissioner and Chief Scientist announce decision to withdraw approval of Makena
6 April 2023 - Today, the US FDA announced the final decision to withdraw approval of Makena—a drug that had been ...
Posted by Michael Wonder on 05 Apr 2023
MHRA grants ADvantage Therapeutics Innovative Licensing and Access Pathway designation for novel lead product AD04 for Phase 2b trial in Alzheimer’s sisease
5 April 2023 - ADvantage Therapeutics today announced that the MHRA has granted the Company’s lead compound AD04 an Innovation Passport ...
Posted by Michael Wonder on 05 Apr 2023
Faster UK drug approvals by relying on other countries
5 April 2023 - Safety and efficacy must be prioritised ahead of speed. ...
Posted by Michael Wonder on 05 Apr 2023
Are German drug pricing regulations chasing some drug makers away, causing them to withdraw products from the market?
5 April 2023 - Germany’s pharmaceutical market is the most important one on the European continent. ...